Erythropoietin Resistance in Anemia of Chronic Kidney Disease

Completed

Conditions studied: Anemia, Kidney Failure, Erythropoietin

In brief

Our goal of this pilot project is to identify inflammatory biomarkers that correlate with epo-resistance among CKD patients.

Key facts

Study ID

NCT00526747

Run by

Duke University

People needed

32

Starts

2007-08-01

Expected to finish

2008-06-01

Last updated by the study team

2013-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• prevalent patients greater than or equal to 18 years old with CKD defined as a glomerular filtration rate < 60 cc/min

You may not qualify if…

• active GI bleeding or history of GI bleed in the prior 3 months
• uncontrolled hyperparathyroidism (PTH>500)
• untreated iron deficiency (transferrin saturation < 20% and ferritin < 100
• overt infection
• active hemolysis
• hemoglobinopathies
• known adverse response to erythropoietin
• prior kidney transplant
• aluminum toxicity

Where it is running

• Durham Nephrology Anemia Clinic — Durham, North Carolina, United States
• Duke University Medical Center Anemia Clinic — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.